Denbinobin induces apoptosis by apoptosis-inducing factor releasing and DNA damage in human colorectal cancer HCT-116 cells

Tzu Hsuan Chen, Shiow Lin Pan, Jih Hwa Guh, Chien Chih Chen, Yao Ting Huang, Hui Chen Pai, Che Ming Teng

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Denbinobin is a phenanthraquinone derivative present in the stems of Ephemerantha lonchophylla. We showed that denbinobin induces apoptosis in human colorectal cancer cells (HCT-116) in a concentration-dependent manner. The addition of a pan-caspase inhibitor (zVAD-fmk) did not suppress the denbinobin-induced apoptotic effect, and denbinobin-induced apoptosis was not accompanied by processing of procaspase-3, -6, -7, -9, and -8. However, denbinobin triggered the translocation of the apoptosis-inducing factor (AIF) from the mitochondria into the nucleus. Small interfering RNA targeting of AIF effectively protected HCT-116 cells against denbinobin-induced apoptosis. Denbinobin treatment also caused DNA damage, activation of the p53 tumor suppressor gene, and upregulation of numerous downstream effectors (p21 WAF1/CIP1, Bax, PUMA, and NOXA). A HCT-116 xenograft model demonstrated the in vivo efficacy and low toxicity of denbinobin. Taken together, our findings suggest that denbinobin induces apoptosis of human colorectal cancer HCT-116 cells via DNA damage and an AIF-mediated pathway. These results indicate that denbinobin has potential as a novel anticancer agent.

Original languageEnglish
Pages (from-to)447-457
Number of pages11
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume378
Issue number5
DOIs
Publication statusPublished - Nov 2008
Externally publishedYes

Fingerprint

Apoptosis Inducing Factor
HCT116 Cells
DNA Damage
Colorectal Neoplasms
Apoptosis
denbinobin
Caspase Inhibitors
Tumor Suppressor Genes
Heterografts
Caspase 3
Antineoplastic Agents
Small Interfering RNA
Mitochondria
Up-Regulation

Keywords

  • AIF
  • Anticancer
  • Caspase-independent
  • Denbinobin
  • DNA damage

ASJC Scopus subject areas

  • Pharmacology

Cite this

Denbinobin induces apoptosis by apoptosis-inducing factor releasing and DNA damage in human colorectal cancer HCT-116 cells. / Chen, Tzu Hsuan; Pan, Shiow Lin; Guh, Jih Hwa; Chen, Chien Chih; Huang, Yao Ting; Pai, Hui Chen; Teng, Che Ming.

In: Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 378, No. 5, 11.2008, p. 447-457.

Research output: Contribution to journalArticle

Chen, Tzu Hsuan ; Pan, Shiow Lin ; Guh, Jih Hwa ; Chen, Chien Chih ; Huang, Yao Ting ; Pai, Hui Chen ; Teng, Che Ming. / Denbinobin induces apoptosis by apoptosis-inducing factor releasing and DNA damage in human colorectal cancer HCT-116 cells. In: Naunyn-Schmiedeberg's Archives of Pharmacology. 2008 ; Vol. 378, No. 5. pp. 447-457.
@article{26666ce5126e444282d617f058dd75c1,
title = "Denbinobin induces apoptosis by apoptosis-inducing factor releasing and DNA damage in human colorectal cancer HCT-116 cells",
abstract = "Denbinobin is a phenanthraquinone derivative present in the stems of Ephemerantha lonchophylla. We showed that denbinobin induces apoptosis in human colorectal cancer cells (HCT-116) in a concentration-dependent manner. The addition of a pan-caspase inhibitor (zVAD-fmk) did not suppress the denbinobin-induced apoptotic effect, and denbinobin-induced apoptosis was not accompanied by processing of procaspase-3, -6, -7, -9, and -8. However, denbinobin triggered the translocation of the apoptosis-inducing factor (AIF) from the mitochondria into the nucleus. Small interfering RNA targeting of AIF effectively protected HCT-116 cells against denbinobin-induced apoptosis. Denbinobin treatment also caused DNA damage, activation of the p53 tumor suppressor gene, and upregulation of numerous downstream effectors (p21 WAF1/CIP1, Bax, PUMA, and NOXA). A HCT-116 xenograft model demonstrated the in vivo efficacy and low toxicity of denbinobin. Taken together, our findings suggest that denbinobin induces apoptosis of human colorectal cancer HCT-116 cells via DNA damage and an AIF-mediated pathway. These results indicate that denbinobin has potential as a novel anticancer agent.",
keywords = "AIF, Anticancer, Caspase-independent, Denbinobin, DNA damage",
author = "Chen, {Tzu Hsuan} and Pan, {Shiow Lin} and Guh, {Jih Hwa} and Chen, {Chien Chih} and Huang, {Yao Ting} and Pai, {Hui Chen} and Teng, {Che Ming}",
year = "2008",
month = "11",
doi = "10.1007/s00210-008-0324-5",
language = "English",
volume = "378",
pages = "447--457",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Denbinobin induces apoptosis by apoptosis-inducing factor releasing and DNA damage in human colorectal cancer HCT-116 cells

AU - Chen, Tzu Hsuan

AU - Pan, Shiow Lin

AU - Guh, Jih Hwa

AU - Chen, Chien Chih

AU - Huang, Yao Ting

AU - Pai, Hui Chen

AU - Teng, Che Ming

PY - 2008/11

Y1 - 2008/11

N2 - Denbinobin is a phenanthraquinone derivative present in the stems of Ephemerantha lonchophylla. We showed that denbinobin induces apoptosis in human colorectal cancer cells (HCT-116) in a concentration-dependent manner. The addition of a pan-caspase inhibitor (zVAD-fmk) did not suppress the denbinobin-induced apoptotic effect, and denbinobin-induced apoptosis was not accompanied by processing of procaspase-3, -6, -7, -9, and -8. However, denbinobin triggered the translocation of the apoptosis-inducing factor (AIF) from the mitochondria into the nucleus. Small interfering RNA targeting of AIF effectively protected HCT-116 cells against denbinobin-induced apoptosis. Denbinobin treatment also caused DNA damage, activation of the p53 tumor suppressor gene, and upregulation of numerous downstream effectors (p21 WAF1/CIP1, Bax, PUMA, and NOXA). A HCT-116 xenograft model demonstrated the in vivo efficacy and low toxicity of denbinobin. Taken together, our findings suggest that denbinobin induces apoptosis of human colorectal cancer HCT-116 cells via DNA damage and an AIF-mediated pathway. These results indicate that denbinobin has potential as a novel anticancer agent.

AB - Denbinobin is a phenanthraquinone derivative present in the stems of Ephemerantha lonchophylla. We showed that denbinobin induces apoptosis in human colorectal cancer cells (HCT-116) in a concentration-dependent manner. The addition of a pan-caspase inhibitor (zVAD-fmk) did not suppress the denbinobin-induced apoptotic effect, and denbinobin-induced apoptosis was not accompanied by processing of procaspase-3, -6, -7, -9, and -8. However, denbinobin triggered the translocation of the apoptosis-inducing factor (AIF) from the mitochondria into the nucleus. Small interfering RNA targeting of AIF effectively protected HCT-116 cells against denbinobin-induced apoptosis. Denbinobin treatment also caused DNA damage, activation of the p53 tumor suppressor gene, and upregulation of numerous downstream effectors (p21 WAF1/CIP1, Bax, PUMA, and NOXA). A HCT-116 xenograft model demonstrated the in vivo efficacy and low toxicity of denbinobin. Taken together, our findings suggest that denbinobin induces apoptosis of human colorectal cancer HCT-116 cells via DNA damage and an AIF-mediated pathway. These results indicate that denbinobin has potential as a novel anticancer agent.

KW - AIF

KW - Anticancer

KW - Caspase-independent

KW - Denbinobin

KW - DNA damage

UR - http://www.scopus.com/inward/record.url?scp=54249113934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54249113934&partnerID=8YFLogxK

U2 - 10.1007/s00210-008-0324-5

DO - 10.1007/s00210-008-0324-5

M3 - Article

VL - 378

SP - 447

EP - 457

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

SN - 0028-1298

IS - 5

ER -